Zogenix reported $224.3M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 566.96M 2.12M
Acura Pharmaceuticals ACUR:US 382K 6.52M
Adamas Pharmaceuticals ADMS:US -21606000 17.57M
Aerie Pharmaceuticals AERI:US $ -72.88M 33.26M
Alnylam Pharmaceuticals ALNY:US $ 755.89M 97.47M
Arena Pharmaceuticals ARNA:US $ 800.72M 170.36M
AstraZeneca AZN:LN 39744M 24068M
Becton, Dickinson and BDX:US $ 23677M 458M
Biocryst Pharmaceuticals BCRX:US $ -147.04M 40.97M
Biogen BIIB:US $ 10429.9M 322M
Cardinal Health CAH:US 1.39B 398M
Esperion Therapeutics ESPR:US $ -362705000 58.4M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
GlaxoSmithKline GSK:LN 15426M 49M
Gw Pharmaceuticals GWPH:US $ 736.37M 4.72M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Intra Cellular Therapies ITCI:US $ 486.76M 66.83M
Marinus Pharmaceuticals MRNS:US $ 78.49M 16.57M
Nektar Therapeutics NKTR:US $ 801.54M 103.44M
Neurocrine Biosciences NBIX:US $ 1346M 66.8M
Revance Therapeutics RVNC:US $ 120.16M 66.07M
Sarepta Therapeutics SRPT:US $ 469.53M 15.58M
Teva Pharmaceutical TEVA:IT 10.47B 143M
Zogenix ZGNX:US $ 224.3M 48.56M